2m 2m 2m 2m 2m 2m 2m
10X GENOMICS-A (TXG)
NASDAQ
$31.34-$0.53 (-1.66%)
Price as of Jun 23, 2026 7:55 PM EDT- $3.8BMarket Cap
- 205.28%1-Year Change
- Health Information ServicesIndustry
10X GENOMICS-A (TXG)
$31.34-$0.53 (-1.66%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 596.7M -2.31% | 610.8M -1.28% | 618.7M +19.81% | 516.4M +5.28% | |
Cost of Revenue | 198.9M +1.34% | 196.3M -6.26% | 209.4M +73.95% | 120.4M +62.48% | |
Gross Profit | 443.9M +7.09% | 414.5M +1.26% | 409.3M +3.36% | 396.0M -4.89% | |
Sales and Marketing Expense | 316.1M -8.19% | 344.3M +0.30% | 343.3M +15.10% | 298.3M +15.82% | |
Research and Development Expense | -238.6M -9.85% | -264.7M -2.08% | -270.3M -201.76% | 265.7M +25.46% | |
Depreciation and Amortization Expense | 36.2M +0.89% | 35.9M +1.03% | 35.5M +39.99% | 25.4M +20.13% | |
Total Operating Expenses | 504.9M -17.10% | 609.0M -9.72% | 674.6M +19.62% | 564.0M +20.34% | |
Operating Profit | -61.0M -68.65% | -194.6M -26.67% | -265.3M +57.99% | -167.9M +221.41% | |
Interest Income | 20.0M +8.67% | 18.4M +9.12% | 16.9M +154.34% | 6.6M +3,126.70% | |
Interest Expense | N/A N/A | N/A N/A | -33,000 -93.07% | -476,000 -45.03% | |
Interest Income and Expense and Net | 20.0M +8.67% | 18.4M +9.33% | 16.9M +153.84% | 6.6M +3,126.70% | |
Total Nonoperating Income and Expense | 21.1M +25.03% | 16.9M +1.77% | 16.6M +177.35% | 6.0M +508.55% | |
Income before Taxes | -39.9M -77.54% | -177.7M -28.57% | -248.8M +53.58% | -162.0M +201.54% | |
Income Taxes | 3.6M -26.18% | 4.9M -22.24% | 6.3M +57.26% | 4.0M -10.63% | |
Extraordinary Items | N/A N/A | 3.1M -68.98% | 9.8M N/A | N/A N/A | |
Net Income | -43.5M -76.16% | -182.6M -28.41% | -255.1M +53.67% | -166.0M +185.11% | |
Net Income from Continuing Operations Applicable to Common | -39.9M -77.54% | -177.7M -28.57% | -248.8M +53.58% | -162.0M +201.54% | |
Basic EPS and Net Income | -0.35 -76.97% | -1.52 -30.28% | -2.18 +49.32% | -1.46 +175.47% | |
Diluted EPS and Net Income | -0.35 -76.97% | -1.52 -30.28% | -2.18 +49.32% | -1.46 +175.47% | |
Basic Weighted Average Shares | 124.7M +3.57% | 120.5M +2.81% | 117.2M +2.90% | 113.9M +3.18% | |
Diluted Weighted Average Shares | 124.7M +3.57% | 120.5M +2.81% | 117.2M +2.90% | 113.9M +3.18% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 474.0M +37.75% | 344.1M -4.24% | 359.3M +63.50% | 219.7M -62.59% | |
Short-Term Investments | 49.4M +0.22% | 49.3M +67.74% | 29.4M -86.01% | 210.2M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 523.4M +33.05% | 393.4M +1.21% | 388.7M -9.60% | 430.0M -26.80% | |
Total Current Assets | 684.5M +17.12% | 584.4M -1.95% | 596.0M -6.14% | 635.0M -15.06% | |
Accumulated Depreciation | 153.5M +24.80% | 123.0M +18.82% | 103.5M +50.36% | 68.8M +40.41% | |
Property and Plant and Equipment and Net | 226.7M -10.27% | 252.6M -9.63% | 279.6M -3.37% | 289.3M +70.70% | |
Total Long-Term Assets | 2.9M -29.45% | 4.1M +34.85% | 3.1M +28.01% | 2.4M -27.93% | |
Total Assets | 1.0B +13.36% | 918.6M -4.82% | 965.1M -6.20% | 1.0B +1.00% | |
Income Taxes Payable | 7.2M +46.25% | 4.9M -2.24% | 5.0M +23.78% | 4.1M -11.75% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 153.5M +30.45% | 117.6M -7.49% | 127.2M -2.90% | 131.0M +18.67% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 6.5M +28.67% | 5.0M +17.64% | 4.3M -30.39% | 6.1M -25.47% | |
Total Liabilities | 245.0M +17.52% | 208.5M -6.96% | 224.1M +0.39% | 223.2M +10.92% | |
Retained Earnings | -1.5B +2.97% | -1.5B +14.22% | -1.3B +24.78% | -1.0B +19.23% | |
Total Stockholders Equity | 796.3M +12.14% | 710.1M -4.17% | 741.0M -8.03% | 805.7M -1.45% | |
Total Shares Outstanding | 127.7M +4.42% | 122.3M +2.68% | 119.1M +3.39% | 115.2M +2.38% | |
Cash Flow | |||||
Cash from Operating Activities | 136.1M +1,941.57% | 6.7M +143.85% | -15.2M -54.78% | -33.6M +57.24% | |
Capital Expenditures | 5.9M -52.11% | 12.4M -74.50% | 48.6M -63.09% | 131.7M +30.00% | |
Cash from Investing Activities | -13.4M -58.82% | -32.6M -124.44% | 133.5M +138.04% | -350.9M +228.76% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 6.8M -37.67% | 10.9M -20.16% | 13.7M -13.58% | 15.8M -55.19% | |
Financials Ratio | |||||
Gross Margin | 66.66% -1.77% | 67.86% +2.58% | 66.15% -13.74% | 76.69% -9.67% | |
Operating Margin | -10.22% -67.91% | -31.85% -25.72% | -42.88% +31.86% | -32.52% +205.27% | |
Return on Assets | -4.44% -77.08% | -19.39% -24.22% | -25.59% +57.81% | -16.21% +171.24% | |
Return on Equity | -5.78% -77.03% | -25.17% -23.69% | -32.98% +61.28% | -20.45% +173.40% | |
Revenue Growth | -2.31% +79.81% | -1.28% -106.48% | 19.81% +274.95% | 5.28% -91.76% | |
Current Ratio | 4.46 -10.22% | 4.97 +5.99% | 4.69 -3.34% | 4.85 -28.42% | |
Cash Ratio | 3.09 +5.60% | 2.92 +3.52% | 2.83 +68.38% | 1.68 -68.48% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow